Single-herb refills with a lab report for every batch and a real Ayurveda doctor
TL;DR Herbrefill sells common Ayurvedic herbs such as ashwagandha, triphala and brahmi as monthly refills. Each batch is tested at an accredited lab for species identity, heavy metals and microbes, and the report is one scan away. A registered Ayurveda doctor, not an algorithm, decides what goes in a customer's box.
Do you actually know what's inside that bottle of ashwagandha? Most buyers don't, and the numbers say they're right to worry. A 2019 review of DNA tests on 5,957 herbal products from 37 countries found 27% adulterated. Of the 752 Indian products in that review, 235 failed, which is 31%[1].
Metals are a separate headache. A JAMA study of Ayurvedic medicines sold online found lead, mercury or arsenic in 20.7% of them, with no real difference between Indian-made and US-made products. Three in four of the contaminated ones claimed good manufacturing practice[2], which tells you how much that label is worth.
You can't check any of this yourself, so you end up trusting the ads and the star ratings.
First, the important bit - Herbrefill sells licensed Ayurvedic products or FSSAI-compliant herbal supplements and makes no disease-treatment claims. Any advice for a specific condition comes from a registered Ayurveda practitioner during a consult. The ads follow the Drugs and Magic Remedies Act and the Ayush advertising rule.
The range starts narrow, with 10–15 single herbs and a few classical formulations from licensed contract manufacturers. Every batch goes to an accredited lab for DNA or chemical identity, heavy metals, microbial load and pesticides. A QR code on the pack opens that batch's report, and that includes any batch that failed and was destroyed. You book a video consult, a doctor sets the regimen and refills turn up monthly.
The seed pitched data-driven personalisation, and I dropped it. No trial we found shows algorithm-picked herbs work better, and picking remedies for a condition is a practitioner's job anyway. Reliability is the problem buyers actually have and lab testing is how you prove you've solved it.
The buyer is an urban adult aged 28–55, often already buying Ayurvedic products online, who has read about contamination and wants proof. People already pay ₹749–939 for a single product from a large Ayurvedic D2C brand[3] and ₹999–1,499 for a customised regimen from a quiz-based beauty brand[4]. My working assumption is that a two-herb monthly box sells at ₹700–1,200, with the consult free for subscribers.
Regulators are watching Ayurvedic advertising closely. In 2024 the Supreme Court banned a major Ayurvedic brand's misleading ads and held its leaders in contempt, and Uttarakhand's licensing authority acted against 14 product licences[5]. FSSAI's nutraceutical regulations took effect in April 2022[6], so the route for herbal supplements is clearer now. A brand that claims less and proves more is a lot easier to defend.
There's no published figure for an Indian herbal-subscription market. The closest neighbour - IBEF puts India's Ayush manufacturing industry at US$24 billion in 2024 (about ₹2.3 lakh Cr)[7]. Treat that as the size of the shelf, not your market.
The sharper signal is the adulteration data above[1]. Close to one Indian product in three failed identity checks, and that gives a tested brand something real to say.
One large Ayurvedic D2C brand sells juices, tablets and foods at scale, but its storefront makes no lab-testing claims[3]. An Ayurveda clinic chain offers free consults and says it customises prescriptions for each patient[8]. A beauty brand sells quiz-based customised hair and skin regimens[4].
We found no Indian herbal brand that shows a test report for every batch it sells. That's the gap, though a well-funded incumbent could close it quickly.
| Difficulty | Moderate (45/100) |
| Starting capital | ₹88 L–1.65 Cr |
| Time to launch | 6–9 months |
The product is simple. The hard parts are regulatory and commercial, and you need manufacturing partners who accept batch rejection, ad copy that never wanders into disease claims and a doctor panel that stays clear of sales targets. Getting customers in D2C wellness is expensive, so retention has to carry the economics.
Yes, this needs product approvals before you sell, and the advertising rules shape every page you publish.
Building this outside India? The categories above usually have a local equivalent, so check with your own regulator.
Don't let AI pick herbs for a condition or answer health questions. That's the practitioner's job, and any automated advice risks a disease claim.
Want to work out the AI layer for Herbrefill? Talk to Yash →
Here's what can go south -
I like this one for a founder with D2C or pharma-quality experience who is comfortable selling restraint. If you want to promise cures then this is not your business, honestly.
Before you spend on stock, prove that buyers value the reports. Run two versions of the same product page, one with a batch report and one without, and look for a clear lift in conversion and repeat orders.
My estimate is ₹88 L–1.65 Cr, covering stock, batch testing, the store and early marketing. The kit breaks it down line by line.
Yes. Ayurvedic drugs need a state Ayush manufacturing licence, held by you or your contract maker, and supplements follow FSSAI rules. Ads must also follow the Drugs and Magic Remedies Act.
Probably, because contamination worries buyers everywhere. Herbal products are regulated very differently abroad, so check your own food and medicine regulator first.
The free Herbrefill validation kit has the line-by-line capital breakdown, the effort scoring, the Ayush and FSSAI licensing checklist, a 14-day validation sprint with pass/fail targets, a 90-day launch plan, 10 interview questions for herbal buyers, and 5 assumptions to test. Download the kit →
Thinking of building Herbrefill or something close to it? The make-or-break work is finding manufacturers whose batches pass and keeping the marketing honest, and that's the kind of thing I help founders sort out. If you need a hand, you know where to find me. Talk to Yash →
For illustration only. Names are fictional and ideas hypothetical; sourced facts are real but may be out of date. Nothing here is legal, financial or professional advice, and Yash Khatri is not personally liable for any use of it. Read the full disclaimer.